Cantourage Strengthens European Capital Markets Strategy

Cantourage Group SE, a leading European medical cannabis provider, has taken a strategic step to enhance its presence in capital markets with the appointment of Manuel Taverne as Head of Investor Relations. With over two decades of experience in capital markets, Taverne aims to strengthen Cantourage's engagement with European financial markets.

This move aligns with Cantourage's focus on elevating its profile among institutional and private investors. CEO Philip Schetter emphasized the need for clear communication of Cantourage's unique business model and platform strategy in the highly competitive medical cannabis market.

By intensifying investor relations, Cantourage seeks to improve clarity, transparency, and proactive communication, reinforcing its position as a leading provider in the sector.